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Using Automated Health 
Plan Data to Assess Infection 
Risk from Coronary Artery 
Bypass Surgery
Richard Platt,*†‡ Ken Kleinman,*† Kristin Thompson,*† Rachel S. Dokholyan,*† James 
M. Livingston,*‡ Andrew Bergman,*§ John H. Mason,*# Teresa C. Horan,** Robert P. 
Gaynes,** Steven L. Solomon,** and Kenneth E. Sands*††
We determined if infection indicators were sufficiently consistent across health plans to allow comparison
of hospitals’ risks of infection after coronary artery bypass surgery. Three managed care organizations
accounted for 90% of managed care in eastern Massachusetts, from October 1996 through March 1999.
We searched their automated inpatient and outpatient claims and outpatient pharmacy dispensing files for
indicator codes suggestive of postoperative surgical site infection. We reviewed full text medical records of
patients with indicator codes to confirm infection status. We compared the hospital-specific proportions of
cases with an indicator code, adjusting for health plan, age, sex, and chronic disease score. A total of 536
(27%) of 1,953 patients had infection indicators. Infection was confirmed in 79 (53%) of 149 reviewed
records with adequate documentation. The proportion of patients with an indicator of infection varied sig-
nificantly (p<0.001) between hospitals (19% to 36%) and health plans (22% to 33%). The difference
between hospitals persisted after adjustment for health plan and patients’ age and sex. Similar relation-
ships were observed when postoperative antibiotic information was ignored. Automated claims and phar-
macy data from different health plans can be used together to allow inexpensive, routine monitoring of
indicators of postoperative infection, with the goal of identifying institutions that can be further evaluated to
determine if risks for infection can be reduced.
ecause postoperative surgical site infections are common
complications of medical care, reducing their occurrence
is a component of current efforts to improve patient safety. To
guide these efforts and to measure their success, hospitals
maintain resource-intensive programs to identify these infec-
tions (1–4). However, hospital-based programs detect only a
minority of these infections. A principal contributor to the
poor detection rates of hospital-based systems is the fact that a
large majority of infections manifest after the patient leaves
the hospital (5–13). Additionally, the substantial resources
required to conduct prospective case detection requires some
hospitals to monitor specific types of procedures only periodi-
cally, which means that hospitals may fail to detect problems
that occur while they focus on other procedure types. Finally,
variability in application of surveillance criteria has made
comparing postoperative infection rates between hospitals dif-
ficult (4,14–16). 
We have described the use of diagnoses and procedures
listed on automated billing data and of antibiotic prescriptions
identified through automated pharmacy dispensing data to
identify patients who are likely to have experienced postopera-
tive surgical site infection both before or after discharge from
the hospital (5,17,18). Overall, insurers’ billing and pharmacy
data identified substantially more patients with infection than
did hospital-based surveillance in these studies. 
These findings suggest that health plans’ and insurers’ rou-
tinely collected billing data might be used to supplement hos-
pital-based programs. More importantly, this information
might be used to compare different hospitals’ results. How-
ever, the comparability of data from different health plans for
this purpose has not been assessed. Nor has any attempt been
made to combine information from different health plans;
information from several health plans is often necessary
because the number of procedures for persons in one health
plan is usually too small to allow acceptably precise estimates
of risk. Health plans differ in type, detail, quality, and com-
pleteness of the information they collect and maintain. For
example, health plans vary widely in their prescription drug
coverage and, therefore, in the amount of information they
possess about their members’ antibiotic exposure. 
We assessed the usefulness of using data from several large
health plans to detect patients who may have had an infection
after coronary artery bypass grafting; we wanted to know if
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this information could be used to compare the experience of
different hospitals. Additionally, we assessed the contribution
of pharmacy data to these comparisons to determine the poten-
tial for using data from persons without pharmacy benefits. 
Methods
Study Population
We studied patients who had coronary artery bypass graft
(CABG) surgery from January 1996 through March 1999 and
who received health-care coverage from Harvard Pilgrim
Health Care, Tufts Health Plan, or Blue Cross Blue Shield of
Massachusetts. Harvard Pilgrim and Tufts Health Plan (includ-
ing Secure Horizons, Tufts Health Plan for Seniors, a Medi-
care + Choice managed care plan) are HMOs. Blue Cross
included HMO and indemnity plans. Together, these organiza-
tions accounted for approximately 90% of managed care in
eastern Massachusetts during that time. We focused princi-
pally on procedures performed in four hospitals, which were
members of the Eastern Massachusetts Prevention Epicenter,
and which performed CABG. These institutions performed a
majority of the CABG procedures in the region. CABG proce-
dures at Harvard Pilgrim through June 1997 were described in
a separate report, and so are omitted here. Patients were
excluded who had a second CABG procedure within 30 days
of a previous procedure. 
Although we wanted to restrict the population to persons
with prescription drug coverage, some of the HMOs could not
provide coverage status at the time of surgery. Therefore, we
excluded from our main analysis any persons for whom the
HMO had no claims for any prescription drugs for 180 days
before the date of surgery. Among patients for whom phar-
macy benefit status was provided, pharmacy dispensing (at
least one prescription) 180 days before surgery correlated with
having benefits; 97% of those with some dispensing had a
drug benefit compared to 19% with no drug benefit.
Data Sources
Automated Data
At the time of the study, Tufts Health Plan maintained two
administrative claims systems: one for its commercial plan and
another for a Medicare plan. Harvard Pilgrim maintained three
legacy systems: one derived from a staff model HMO, one
from its network and group division, and one from an IPA sys-
tem. In total, six claims systems were used. HMO staff
searched these six claims systems for hospital claims with
ICD9 procedure codes 36.10–36.16, 36.19, or CPT codes
33510–14, 33516–19, 33521–23, 33533–36 in physician bill-
ing records. For convenience, we refer to each of these claims
systems as a separate plan (i.e., plan 1 through plan 6). These
separate divisions had generally similar benefits (e.g., cover-
ing ambulatory services and prescription drugs except for a
copayment required of the patient). However, one of the plans
changed its coverage during the study period, including a
capped pharmacy benefit for every 3-month period and a
period of no pharmacy coverage. 
For all patients with a procedure code of interest, each
health plan provided the patient’s age and sex. The health
plans also provided inpatient and outpatient claims from the
index hospitalization through 30 days after the date of the sur-
gical procedure. For each claim, they provided an encrypted
patient identifier, a date of service, a service location (inpa-
tient, skilled nursing facility, emergency room, or outpatient),
and all diagnosis and procedure codes. For each prescription,
they provided the same patient identifier, the date of dispens-
ing, and a drug identifier (all provided National Drug Code
and generic names). Some HMOs provided data for all CABG
procedures. Others provided data only for patients whose
CABG procedure was performed at an Epicenter hospital.
However, in those cases they provided follow-up data from
any hospital. We tested the completeness of the claims files in
several ways (e.g., we assessed the number of days per patient
on which ambulatory services were provided and the number
of diagnoses listed on such days). We excluded health plans
from our main analyses if their data appeared to be incom-
plete. The specific reasons for exclusion are described.
For each patient, we identified all claims with any codes
suggestive of surgical site infection (Appendix 1). We refer to
the codes in Appendix 1 as indicators of infection. These
codes included inpatient diagnoses of infection, ambulatory
diagnoses of infection, procedure codes suggestive of infec-
tion, and antibiotics dispensed in the ambulatory setting. This
list is a more general set of codes previously identified as
being important (17,18); we added closely related codes that
had not appeared in our earlier datasets. We also assigned an
estimated probability that infection had occurred by using a
previously described algorithm developed in a dataset that
included a broad range of surgical procedures, including coro-
nary artery bypass (17,18, Appendix 2). Because the algorithm
assigns a higher baseline probability of infection to patients
undergoing cardiac surgery than those undergoing other proce-
dures, 536 (97%) of 550 patients with any of the indicators in
Appendix 1 had an estimated probability of infection exceed-
ing 9.5%. Although we sought to confirm the infection status
of the 536 with probabilities exceeding 9.5%, we refer to them
as patients with any indicator, since this has a functionally
equivalent meaning for patients undergoing CABG. Identify-
ing patients with any indicator is much simpler than identify-
ing patients who exceed a threshold predicted probability of
infection.
Medical Record Information
We attempted to obtain the medical records of patients
who had claims with an indicator of infection. Because most
patients received care from a variety of providers in different
facilities, we requested the record of the first provider or facil-
ity that submitted a claim with an indicator  of infection. In
many cases, identifying an institution to request records from
was not possible. In these cases, we requested the record fromEmerging Infectious Diseases  •  Vol. 8, No. 12, December 2002 1435
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the patient’s primary care physician. For logistical reasons,
reviewing records of patients belonging to one of the health
plans was not possible. 
Patients’ records with an indicator code were reviewed by
trained abstractors for evidence of postoperative surgical site
infections, by using the criteria from the Centers for Disease
Control and Prevention’s National Nosocomial Infection Sur-
veillance System (CDC NNIS) (19). The reviewers also noted
if the information in the medical record was adequate to judge
the presence of infection. Typical reasons that records were
judged inadequate included inappropriate date range of the
records provided or lack of indication that the patient had
received postoperative care from the provider. An infectious
disease specialist reviewed records with evidence of abnormal
wound healing and classified the outcome as confirmed infec-
tion, abnormal wound that met some criteria for infection, or
no evidence of infection. 
Chronic Disease Score
We computed a chronic disease score (the Clark TC score)
(20,21) for each patient, for use as a comorbidity adjuster.
Components of the chronic disease score include the patient’s
age, sex, and prescription medications during the previous 6
months. Points are assigned for 29 diseases or disease catego-
ries (i.e., diabetes, if the patient has any dispensing of a drug
typically used to treat the disease). The chronic disease score
has been shown to predict hospitalization and also to correlate
with the risk for postoperative surgical site infection in a gen-
eral surgery population (22,23). 
Data Analysis
Simple comparisons of categorical data were performed by
chi-square testing. Continuous variables were often not nor-
mally distributed and were compared by nonparametric tests,
either the Wilcoxon if two groups were being compared or the
Kruskal-Wallis test for more than two. The strength of correla-
tion between continuous variables was assessed with the
Spearman correlation coefficient. Logistic regression was used
to investigate a central question in the current investigation
(i.e., if enough consistency existed between plans to allow
comparisons between hospitals). This question was assessed
by using a hospital-by-plan interaction term in the model. The
model also assessed and controlled for the relative contribu-
tion of health plan, hospital, age, sex, and chronic disease
score to the probability of individual patients having a claim
suggestive of infection. 
Results
These health plans provided data for 3,014 CABG proce-
dures performed from January 1996 through March 1999. A
total of 858 patients had no claims for prescription drugs for
180 days before surgery, 46 had claims in two different claims
systems, 39 had an uncertain procedure type, and 7 had a sec-
ond CABG within 30 days. In addition, one of the plans was
unable to provide claims for postoperative ambulatory care for
99% of its patients; claims from this plan were determined to
be unusable because they were incomplete. All 252 persons
represented by this claim system were excluded. We excluded
the 1,061 patients with at least one of these criteria from our
main analyses (some patients met more than one exclusion cri-
terion). The total number of included procedures was 1,953,
representing 65% of all procedures. The median age was 61
years, 78% were men, a median of 15 prescriptions were filled
6 months before surgery, and the median chronic disease score
was 2,283 (Table 1). Postoperatively, a median of five pre-
scriptions were filled in 30 days after surgery. Substantial dif-
ferences existed between the health plans in members’ age,
sex, chronic disease score, and number of prescriptions before
surgery. In the 30 days after surgery, substantial differences
existed in the number of prescriptions (all drugs) and number
of days that patients received ambulatory care. 
Overall, based on claims data alone, at least one indicator
code for surgical site infection was found in 536 (27%) of
1,953 patients, with a range of 22% to 33% in the different
health plans (Table 2). In patients with at least one such indica-
tor code, the estimated probability that infection had occurred,
based on our algorithm, was tightly clustered in two ranges:
one was approximately 10% and the other approximately 70%.
The distribution of estimated probabilities for all patients
together and separately by health plan is shown in Figure 1.
The overall pattern was similar across the health plans,
although the distribution of probabilities was significantly dif-
ferent among them (p<0.01, Kruskal-Wallis). The specific
types of indicators that contributed to patients being classified
as high risk and the locations in which they occurred are
shown in Table 1. Forty-nine (3%) patients had an infection
indicator code during initial hospitalizations. In the 30 days
after surgery, 77 (4%) persons had an indicator during a sec-
ond hospitalization; 48 (62%) of second hospitalization
occurred at the same institution in which surgery had been per-
formed. Forty-three (2%) patients had an infection indicator
during an emergency room visit, 280 (14%) had an indicator
during an ambulatory-care visit, and 291 (15%) were dis-
pensed an antistaphylococcal antibiotic (Table 1). Statistically
significant differences occurred across health plans in the per-
centages of patients who had indicator diagnoses during initial
hospitalization (p=0.05) and rehospitalization (p<0.01), who
had claims for wound cultures (p<0.01) and wound care
(p=0.052), and who received antistaphylococcal antibiotics
(p=0.05) but not in diagnoses in emergency rooms or other
ambulatory settings. 
We requested full text medical records that had infection
indicator codes for 368 patients who were members of plans
that participated in the record review component of this study.
We obtained 275 (75%) of these (Table 3). The health plan
with automated ambulatory medical records retrieved nearly
all requested records; from the others, the proportions ranged
from 66% to 79%. From records obtained, 149 (54%) con-
tained sufficient information to allow assessment of the pres-
ence or absence of postoperative surgical site infection.RESEARCH
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Common reasons for classifying the documentation inade-
quate were lack of any evidence that the provider or facility
had cared for the patient during the 30 days after surgery or
submission of records from a time that excluded this interval.
Records were considered to be adequate if the status of the
incisions during a postoperative visit was not mentioned. From
charts with adequate documentation, 79 (53%) patients were
confirmed to have infection; 70 of these infections were super-
ficial. Another 19 (13%) patients partially satisfied CDC
NNIS criteria for surgical site infection. The confirmation rate
was similar for those with estimated probabilities of infection
of >9%–20% (48%, 35/73) and those with estimated probabil-
ities >50% (59%, 43/73). No substantial difference existed
between either health plans or hospitals in the proportions with
confirmed infection; these proportions exceeded 50% for
every health plan and hospital except one, for which the con-
firmation rate was 45% (data not shown).
Of the four studied hospitals, the proportions of patients
with an indicator of infection varied from 19% to 36% (Table
2). The rank ordering of the hospitals was consistent across the
different health plans, with hospital D having the highest pro-
portion in four plans and hospital B having the lowest in three
of them. Hospital D’s excess, compared to hospitals A and B,
was considerably greater during the year beginning April 1997
than during the year beginning April 1998 (Figure 2). Hospital
B had either the lowest percentage or was close to the lowest
during the 2 years. After these results were known, hospital D
indicated that it had identified an increase in its sternal surgical
site infection rate from July through December 1997 through
hospital-based surveillance and had intervened to address this
Table 1. Characteristics of coronary artery bypass patients of five health-care plans in Massachusetts, January 1996–March 1999
Plan 1 Plan 2 Plan 3 Plan 4 Plan 5 All p valuea
Procedures 161 584 635 363 210 1,953
Age (range)a 67 (61–73) 59 (53–64) 60 (54–65) 59 (53–63) 72 (68–75) 61 (55–67) <0.0001
Sex, % male 77 78 83 80 60 78 <0.0001
Prescriptions (range) during the 180 days 
before surgeryb
14 (9-22) 18 (10-28) 18 (12-27) 9 (6-12) 14 (7-21) 15 (9-24) 0.0001
Chronic disease score (range)b 2,474 
(1,774–3,704)
2,211 
(1,403– 3,456)
2,378 
(1,506–3,662)
2,156 
(1,372–3,350)
2,369 
(1,432–3,376)
2,283
 (1,446–3,511)
0.01
Prescriptions (range) during the 30 days after 
surgery b
5 (3–7) 6 (4–8) 4 (3–6) 5 (3–7) 3 (0–5) 5 (3–7) <0.0001
Days (range) with ambulatory care claims b 1 (1–2) 10 (7–13) 6 (3–8) 11 (8–16) 14 (10–18) 8 (5–13) 0.0001
Diagnoses on days with ambulatory claims 
(average)
2.6 2.6 2.2 1.9 1.5 2.2
Patients with specified indicator of infection %  (no. of patients):
Diagnosis during index hospitalization 6 (9) 3 (17) 2 (14) 2 (7) 1 (2) 3 (49) 0.05
Diagnosis in ambulatory setting (excludes 
emergency room)
12 (19) 15 (89) 17 (105) 11 (39) 13 (28) 14 (280) NS
Diagnosis in emergency rooms 2 (3) 3 (19) 2 (12) 2 (6) 1 (3) 2 (43) NS
Diagnosis during second hospitalization, 
includes extended care facilities
9 (14) 7 (41) 2 (15) 2 (6) 0 (1) 4 (77) <0.01
Antistaphylococcal antibiotic in ambulatory 
setting
16 (26) 18 (107) 13 (81) 14 (52) 12 (25) 15 (291) 0.05
Wound culture performed 2 (3) 2 (12) 5 (33) 6 (22) 1 (2) 4 (72) <0.01
Wound care 0 (0) 1 (4) 2 (15) 1 (5) 1 (2) 1 (26) 0.052
aKruskal-Wallis or chi-square tests of the null hypothesis of no difference between plans.
bMedian (interquartile range).
Figure 1. Distribution of individual patients’ estimated probability of
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increase (pers. comm., hospital D’s epidemiologist). The
increase noted by hospital D overlapped with the two periods
during which claims-based surveillance showed the hospital’s
rate to be high. 
The hospitals were different from one another in the pro-
portion of patients with an indicator of infection (p<0.0001),
after controlling for health plan, patient age, and patient sex.
The adjusted relative odds of a patient’s having an indicator
for infection for hospital D compared to hospital B was 2.3,
with intermediate values for the others (Table 4). Patient age,
sex, and health plan were also significant predictors of an indi-
cator of infection. However, the interaction between health
plan and hospital was not significant, indicating that the risk of
infection at each hospital was not affected by membership in
any particular plan. The adjusted relative risks for the hospitals
were nearly identical in models that substituted the chronic
disease score, which incorporates preoperative prescription
drug information along with age and sex, in place of age and
sex as separate risk factors. Nearly identical results were
obtained when the health plans with highest and lowest values
were excluded from these analyses, either singly or together.
The results were also nearly the same when we included the
969 patients (totaling 2,922 of the original 3,014 cases) who
had been excluded because they had no pharmacy dispensing
activity during the 6 months before surgery or because they
belonged to the health plan that provided no claims for postop-
erative ambulatory care. 
We also assessed the effect of ignoring postoperative anti-
biotic information. In this situation, 363 (18%) of 1,953 per-
sons had an indicator suggestive of infection, compared to
27% when antibiotics were included, using the same model
and setting the contribution of absolute zero. The distribution
of estimated probability that infection had occurred still had
two peaks, clustered as before at 10% and 70% (Figure 1).
These estimated probabilities including and excluding postop-
erative antibiotic information were highly correlated. For all
patients together, the Spearman correlation coefficient was
0.81 (p=0.0001); the health plan specific correlation coeffi-
cients ranged from 0.71 to 0.83. When postoperative antibiotic
dispensing in the ambulatory setting was ignored, qualitatively
similar results regarding the relative odds associated with spe-
cific hospitals were also obtained, although the effect of the
hospital was less strong (p=0.03, Table 4). 
Discussion
These results agree with earlier findings indicating the
value of using automated claims data to identify persons who
are likely to have experienced a postoperative surgical site
infection. In this setting, infection was confirmed in approxi-
mately 58% of patients with an indicator in claims data. These
findings were also consistent with earlier findings that most
infections are detected in ambulatory settings or in hospitals
other than the one in which surgery was performed. This result
is notable in this case because complications of CABG are
probably more likely to be cared for in the institution where
surgery is performed, compared to complications of other
types of procedures. 
A principal reason to use automated data in this way would
be to screen institutions periodically to identify those with
higher than expected proportions of patients with an indicator
of infection. However, a high proportion of patients with indi-
cators does not necessarily imply that a hospital’s infection
rate is high, since the overall confirmation rate may vary
across hospitals and over time. Rather, the finding of a high
proportion with infection indicator codes would allow directed
inquiry about whether these institutions’ actual infection rates
exceeded either their own usual level or the rates for similar
institutions. In our data, the claims data suggested that hospital
D’s rate was high, which was confirmed by the hospital. These
data might also be used to identify institutions with consis-
tently low proportions of patients with indicator codes; these
institutions may be able to assist others in identifying and
implementing best practices. In our case, hospital B may be
Table 2. Patients with indicators of infection by hospital and health maintenance organization claims system 
Hospital
P l a n  1P l a n  2P l a n  3P l a n  4P l a n  5 T o t a l
(% Patients with indicator/all patents)
A 33 (36/108) 33 (45/136) 27 (48/175) 23 (12/53) 16 (7/45) 29 (148/517)
B — 15 (7/41) 21 (54/256) 16 (21/131) 25 (8/32) 19 (89/460)
C 30 (3/10) 56 (9/16) 26 (16/62) 25 (12/48) 11 (3/28) 26 (53/164)
D 100 (1/1) 41 (41/100) 55 (50/141) 34 (29/86) 34 (11/32) 36 (132/360)
Other 31 (13/42) 28 (81/291) 0 (0/1) 27 (12/45) 25 (18/73) 27 (124/452)
All 33 (53/161) 31 (182/584) 26 (168/635) 23 (86/363) 22 (47/210) 27 (536/1953)
Figure 2. Proportion of patients with an indicator of infection, by hospital
and 6-month period.RESEARCH
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such an institution, since its proportion of patients with an
indicator code was usually the lowest of the group. 
Since claims like the ones used here are created for nearly
all patients, performing such screening for most hospitals
would be possible. The type of work involved, manipulation of
automated claims data and review of selected records, is simi-
lar to work already performed by many health maintenance
organizations as part of their accreditation requirements. Such
activities might be integrated with those of peer review organi-
zations, which have experience in working with hospitals to
assess care and to implement changes to improve it. The incre-
mental work for health plans of performing this screening is
relatively small, after the initial work of implementation. 
The data we used were created mainly to support financial
operations; therefore, the underlying data systems differ con-
siderably within and between health plans. Health plans’ data
systems differ (e.g., the number of diagnoses and procedures
per claim that they capture). Additionally, the reliability of
data can vary in ways not appreciated by the health plans
themselves. For example, we found that one health plan identi-
fied no claims for postoperative ambulatory care. Limiting
assessment to patients and procedures for which the overall
patterns of care appear to be appropriate is important. 
Health plans themselves differ in a variety of ways that
may influence the proportion of patients with indicators for
infection, including the patient populations they serve. These
populations may differ in their underlying risk for infection. In
the health plans we studied, the different distributions of age,
sex, and chronic disease scores illustrate this point. The differ-
ent benefits packages of the health plans also cause differences
in the proportion with indicators. For example, one of the
health plans had limited prescription drug coverage. There-
fore, comparisons between health plans’ results must be made
with care. 
The differences between the health plans did not affect our
inter-hospital comparisons, shown in Table 4. We interpret this
result to mean that combining results from different health
plans is possible, as long as the comparisons control for health
plan. Combining results to obtain sufficient numbers of proce-
dures and stable estimates of risk is desirable. Consistency of
effect across insurers provides additional support for the com-
parisons. 
Differences between hospitals’ proportions of patients
with infection indicator codes may reflect a difference in the
actual risk of infection, but they may also result from system-
atic differences in the way they or their clinicians assign diag-
nosis and procedure codes or report them to payers. Because
of these potential differences, outlier values observed in claims
data should be confirmed by direct assessment of clinical out-
comes. For this reason and others, a hospital’s proportion of
patients with indicator codes should not be equated with its
infection rate. 
Because our record review confirmed similar proportions
of infections among patients with low and high estimated risks
of infection, we recommend focusing on all patients with any
of the indicators, rather than those with higher estimated prob-
abilities of infection. Focusing on all patients with an indicator
of infection eliminates some of the potential sources of unin-
Table 3. Infections noted in full text medical record reviewa
Plan 1 Plan 2 Plan 4 Plan 5 All
Records sought 53 182 86 47 368
Records obtained (%) 51 (96) 125 (69) 68 (79) 31 (66) 275 (75)
Adequate documentation (% of records received) 45 (88) 62 (50) 29 (43) 13 (42) 149 (54)
Adequate documentation among records sought 45 (85) 62 (34) 29 (34) 13 (28) 149 (40)
Surgical site status (% of those with adequate documentation)
Confirmed surgical site infection 23 (51) 31 (50) 15 (52) 10 (77) 79 (53)
Problem wound healing, not meeting criteria for infection.  7 (16) 7 (11) 3 (10) 2 (15) 19 (13)
No evidence of infection 15 (33) 24 (31) 11 (38) 1 (8) 51 (34)
aFor logistical reasons, records were not sought from plan 3. 
Table 4. Adjusted hospital specific risksa
Patients with at least one 
indicator code for infection Hospital B vs. A Hospital C vs. A Hospital D vs. A Other hospitals vs. A p value
Including pharmacy data 536/1,953 0.68 
(0.49–0.94)b
1.03 
(0.68–1.55)
1.57 
(1.16–2.13)
0.91 
(0.67–1.24)
<0.0001
Excluding pharmacy data 363/1,953 0.84 
(0.58–1.20)
0.92 
(0.56–1.50)
1.62 
(1.15–2.28)
1.05 
(0.74–1.50)
0.03
aAdjusted for health plan, age, and sex. The interaction between health plan and hospital was not significant in any of these models. Similar results were obtained in models adjusting 
for chronic disease score (a composite of age, sex, and pharmacy information), instead of age and sex. 
bAdjusted odds ratios and (95% confidence intervals). Emerging Infectious Diseases  •  Vol. 8, No. 12, December 2002 1439
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formative variation between hospitals and health plans, since
the estimation of risk for each patient uses combinations of
specific codes. In addition, the larger number of events pro-
vides more stable estimates and therefore facilitates compari-
sons. The relatively small number of confirmed deep
infections prevented assessment of differential ability of this
method to identify different types of surgical site infections.
We do not know whether the fact that 89% of confirmed infec-
tions were superficial reflects the actual epidemiology of sur-
gical site infections or differential ascertainment of deep
infections, which are likely to be diagnosed and treated in the
inpatient setting. Our earlier work (18) suggested the approach
we used had good sensitivity for detecting infections diag-
nosed among inpatients. 
Although pharmacy claims are an indicator of infection,
sometimes the only indicator, we obtained qualitatively similar
results when we ignored this information. Therefore, we
believe claims data can be assessed even when pharmacy
claims are unavailable. However, controlling for the availabil-
ity of this information will be important when making compar-
isons. Although automated ambulatory medical records are
still not widely used, using their information when it is avail-
able is worthwhile, since this information is typically more
complete. The same caveat will apply about controlling for
automated medical records versus claims data as the data
source. 
We cannot directly extrapolate these results regarding cor-
onary artery bypass to other types of procedures. For instance,
ICD9 code 998.5 (postoperative infection) may be much less
specific when assigned during hospitalizations for other types
of surgical procedures. For example, the code may be assigned
during a hospitalization for breast surgery to treat pre-existing
infection. Because of this, the usefulness of these indicators
for common procedure types should be determined. However,
earlier work did indicate usefulness of indicators obtained
from automated data for an unselected set of nonobstetric pro-
cedures (17) and separately for identification of postpartum
infection (23). 
We conclude that automated claims systems currently
maintained by most health plans and insurers to reimburse
institutions, providers, and pharmacies can serve as the basis
for a screening system that would allow assessment of most
hospitals’ outcomes of coronary artery bypass procedures and
possibly of other procedure types. Such screening would allow
focused follow-up of specific institutions to determine if their
infection rates actually are high and if specific practices can be
changed to reduce the risk to patients. Such screening systems
will be particularly useful if different health plans combine
their results. The effort required to implement a system that
includes a majority of hospitals that perform coronary artery
surgery is not large in relation to existing quality improvement
programs and would provide information that complements
existing programs for identification and control of surgical site
infections. 
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Appendix 1. 
Antibiotics, diagnosis, and procedure codes used to identify potential
infectionsa
Antibioticsb
Cephalexin
Dicloxacillin
Clindamycin
Cephradine 
Vancomycin
Diagnoses assigned in hospitals, emergency 
departments, or outpatient settings (ICD9 codes)
998.0  Postoperative  Shock 
998.3  Post-op Wound Disruption 
998.5 Postoperative  Infection 
998.51 Infected Post-op Seroma 
998.59 Post-op Infection Nec 
998.83 Non-Healing Surg Wnd 
780.6 Fever 
891.0  Op Wnd Low Leg /S Comp 
891.1  Open Wnd Knee/Leg-Comp 
682.6 Cellulitis  of  Leg 
682.9 Cellulitis  Nos 
998.9  Surgical Comp Nos 
38.0 Streptococcal  Septicemia 
38.1 Staph  Septicemia 
38.10 Staph Septicemia Nos 
38.11 Staph Aureus Septicemia 
38.19 Staph Septicemia Nec 
38.2 Pneumococcal  Septicemia 
38.3 Anaerobic  Septicemia 
38.4  Gram-Neg Septicemia Nec 
38.40 Gram-Neg Septicemia Nos 
38.41 H. influenzae Septicemia
38.42 E. coli Septicemia
38.43 Pseudomonas Septicemia
38.44 Serratia Septicemia
38.49 Oth Gram-Neg Septicemia
38.8 Septicemia  Nec 
38.9 Septicemia  Nos 
790.7 Bacteremia 
611.0  Inflam Disease of Breast 
682.0 Cellulitis  of  Face 
682.1 Cellulitis  of  Neck 
682.2 Cellulitis  of  Trunk 
682.3 Cellulitis  of  Arm 
682.4 Cellulitis  of  Hand 
682.5 Cellulitis  of  Buttock 
682.6 Cellulitis  of  Leg 
682.7 Cellulitis  of  Foot RESEARCH
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682.8  Cellulitis, Site Nec
682.9 Cellulitis  Nos 
686.0 Pyoderma 
686.1 Pyogenic  Granuloma 
686.8  Local Skin Infection Nec 
686.9  Local Skin Infection Nos 
958.3  Posttraum Wnd Infect Nec 
711.00 Pyogen Arthritis-Unspec 
996.6 Infect/Inflam-Dev/Graft 
996.60 Infect Due To Device Nos 
996.61 Infect D/T Hrt Device 
996.62 Infect D/T Vasc Device 
996.63 Infect D/T Nerv Device
996.64 Infect D/T Urethral Cath 
996.65 Infect D/T GU Device Nec
996.66 Infect D/T Joint Prosth 
996.67 Infect D/T Orth Dev Nec
996.68 Infect D/T PD Cath 
996.69 Infect Due To Device Nec
674.3  Oth Comp OB Surg Wound 
879.0  Open Wound of Breast 
879.1  Open Wound Breast-Comp 
879.2  Opn Wnd Anterior Abdomen 
879.3  Opn Wnd Ant Abdomen-Comp
879.4  Opn Wnd Lateral Abdomen
879.5  Opn Wnd Lat Abdomen-Comp
879.6  Open Wound of Trunk Nec 
879.7  Open Wnd Trunk Nec-Comp
879.8  Open Wound Site Nos 
879.9  Opn Wound Site Nos-Comp
875.0  Open Wound-Chest/S Comp
875.1  Open Wound Chest-Comp
Specimens obtained for culture (CPT codes)
87040 Blood Culture for Bacteria
87072 Culture of Specimen by Kit
87075 Culture Specimen, Bacteria
87076 Bacteria Identification
87081 Bacteria Culture Screen
87082 Culture of Specimen by Kit
87083 Culture of Specimen by Kit
87084 Culture of Specimen by Kit
Wound care procedures (CPT codes)
10180 Complex Drainage Wound
11000 Debride Infected Skin
11001 Debride Infect Skin Add
15852 Dressing Change, Not for Burn
aSome of these codes are applicable principally to surgical procedures
other than CABG. They were included during the development of the algo-
rithm shown in Appendix 2, which was developed to include CABG and other
procedures [XXREF]. For consistency, these codes were retained in this evalu-
ation of CABG procedures alone.
bThese antibiotics were identified by an ambulatory pharmacy claim.
Appendix 2. 
Algorithm used to assign probability that infection had occurred
p = exp (α  + 1x1 + …  + nxn)/(1 + exp (α  + 1x1 + …  + 9x9)), where 
α  = –5.16
β 1 = +3.03
x1 = dispensing any of five selected antibiotics
β 2 = +6.06
x2 = any selected diagnosis in hospital 
β 3 = +1.05
x3 = any selected diagnosis in emergency dept (if x2 = 0)
β 4 = +2.98
x4 = any selected diagnosis in outpatient setting 
β 5 = +2.91
x5 = selected bacterial culture
β 6= +1.91
x6 = wound care
β 7 = –1.79
x7 = interaction of x4 and x6
β 8 = –2.70
x8 = interaction of x4 and x2
β 9 = –2.21
x9 = interaction of x4 and x5
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